Of the cluster of differentiation antigens, CD59 and CD82 were found to be significantly differentially expressed when comparing poor and good risk subgroups in adult AML (p = 2.09 × 10−12 and p = 6.60 × 10−11, respectively). This evidence concerns the gene CD59 and acute myeloid leukemia.